AGT and triple-A syndrome: As a mouse model of AAA, we used control apolipoprotein E‐deficient (apoeKO) mice and Atg7cKO (SMC‐specific Atg7‐deficient mice):apoeKO mice administered angiotensin II for 4 weeks.